黑料网官网

UCB Pharmaceuticals is a global biopharmaceutical company focusing on central nervous system diseases and immune system diseases. UCB Pharmaceuticals' total global sales increased to 鈧�4.5 billion in 2017. More than 7,500 employees work in many countries around the world under the slogan 鈥淚nspired by patients, driven by science.鈥� For the future, UCB is building a solid platform to continue its growth based on its core product lines, while also developing the research pipeline that was established early on.